Education
About Us
Working with TipRanks
Follow Us
Resonate Blends (KOAN)
OTHER OTC:KOAN
KOAN Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
Volume5.61M
Average Volume (3M)10.87M
Market Cap
$2.83M
Enterprise ValueN/A
Total Cash (Recent Filing)$13.43K
Total Debt (Recent Filing)$4.27M
Price to Earnings (P/E)―
Beta1.19
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding195,248,780
10 Day Avg. Volume10,867,509
30 Day Avg. Volume10,867,509
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.11
Price to Sales (P/S)0.18
P/FCF Ratio-0.33
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Resonate Blends News
KOAN FAQ
What was Resonate Blends’s price range in the past 12 months?
Resonate Blends lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Resonate Blends’s market cap?
Resonate Blends’s market cap is $2.83M.
When is Resonate Blends’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Resonate Blends’s earnings last quarter?
Currently, no data Available
Is Resonate Blends overvalued?
According to Wall Street analysts Resonate Blends’s price is currently Overvalued.
Does Resonate Blends pay dividends?
Resonate Blends does not currently pay dividends.
What is Resonate Blends’s EPS estimate?
Resonate Blends’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Resonate Blends have?
Resonate Blends has 195,248,780 shares outstanding.
What happened to Resonate Blends’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Resonate Blends?
Currently, no hedge funds are holding shares in KOAN
Company Description
Resonate Blends
APOLLO BioWellness Inc. engages in the discovery, development, and marketing of products for mankind in the field of regenerative medicine. It focuses on marketing licensed patent-pending natural stem cell mobilizing agents for enhancing individual's ability to mobilize their own adult stem cells from their bone marrow. The company also has a license to market a dual acting all-natural diet aid to help control hunger through normal body signals to the brain and stomach. In addition, it is involved in the research and development activities focusing on exploring other areas, such as Secretogues to enhance a person's own growth hormone production and similar natural bioactive formulations to enhance human performance utilizing known body mechanisms without the use of drugs. The company is based in North Bergen, New Jersey.
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---